Literature DB >> 3289078

MR contrast enhancement of intracranial lesions with Gd-DTPA.

J R Hesselink1, G A Press.   

Abstract

Gd-DTPA is a paramagnetic contrast agent for MR that produces enhancement of lesions on T1-weighted images. Since it does not cross the intact blood-brain barrier (BBB), Gd-DTPA enhances only those pathologic processes that are associated with breakdown of the BBB and structures or lesions that are devoid of a BBB. Gd-DTPA improves conspicuity, helps characterize and delineate the extent of lesions, and increases the sensitivity for detection of cerebral abnormalities.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289078

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  10 in total

1.  Magnetic resonance imaging in oncology.

Authors:  J E Husband; R Guy
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

2.  Fluorescein-Guided Surgery for Pediatric Brainstem Gliomas: Preliminary Study and Technical Notes.

Authors:  Zhan Xue; Lu Kong; Chang-Cun Pan; Zhen Wu; Jun-Ting Zhang; Li-Wei Zhang
Journal:  J Neurol Surg B Skull Base       Date:  2018-06-25

3.  Gadolinium in magnetic resonance imaging of the central nervous system.

Authors:  A N Hasso
Journal:  West J Med       Date:  1990-01

Review 4.  Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.

Authors:  Sagar Agarwal; Ramola Sane; Rajneet Oberoi; John R Ohlfest; William F Elmquist
Journal:  Expert Rev Mol Med       Date:  2011-05-13       Impact factor: 5.600

5.  Gadolinium enhanced magnetic resonance imaging in the diagnosis of anterior visual pathway meningiomas.

Authors:  M G Alper; J L Sherman
Journal:  Trans Am Ophthalmol Soc       Date:  1989

6.  Transferrin-coated gadolinium nanoparticles as MRI contrast agent.

Authors:  Huedayi Korkusuz; Karsten Ulbrich; Katerina Welzel; Verena Koeberle; Waralee Watcharin; Ute Bahr; Valery Chernikov; Thomas Knobloch; Sabine Petersen; Frank Huebner; Hanns Ackermann; Svetlana Gelperina; Wolfgang Kromen; Renate Hammerstingl; Joerg Haupenthal; Frank Gruenwald; Jens Fiehler; Stefan Zeuzem; Joerg Kreuter; Thomas J Vogl; Albrecht Piiper
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

7.  Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib.

Authors:  Elizabeth R Gerstner; Poe-Jou Chen; Patrick Y Wen; Rakesh K Jain; Tracy T Batchelor; Gregory Sorensen
Journal:  Neuro Oncol       Date:  2010-01-22       Impact factor: 12.300

8.  Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study.

Authors:  Jaishri O Blakeley; Jeffrey Olson; Stuart A Grossman; Xiaoying He; Jon Weingart; Jeffrey G Supko
Journal:  J Neurooncol       Date:  2008-09-12       Impact factor: 4.130

9.  Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.

Authors:  Omid Veiseh; Conroy Sun; Chen Fang; Narayan Bhattarai; Jonathan Gunn; Forrest Kievit; Kim Du; Barbara Pullar; Donghoon Lee; Richard G Ellenbogen; Jim Olson; Miqin Zhang
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

10.  Low grade gliomas: comparison of intraoperative ultrasound characteristics with preoperative imaging studies.

Authors:  P D Le Roux; M S Berger; K Wang; L A Mack; G A Ojemann
Journal:  J Neurooncol       Date:  1992-06       Impact factor: 4.130

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.